or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    REGN B Regeneron Pharmaceuticals, Inc. 0.32
    CORT B Corcept Therapeutics Incorporated 1.81
    LFST C LifeStance Health Group, Inc. 4.52
    IGC C India Globalization Capital Inc. 0.97
    CGTX C Cognition Therapeutics, Inc. 0.52
    ELDN C Eledon Pharmaceuticals, Inc. -5.19
    OMER C Omeros Corporation 6.84
    ELYM C Eliem Therapeutics, Inc -0.59
    DXR C Daxor Corporation -1.60
    CPRX C Catalyst Pharmaceutical Partners, Inc. 1.76
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Medicine Biopharmaceutical Clinical Research Epilepsy Pain Pharmaceutical Psychiatric Diagnosis Alzheimer's Disease Biotechnology Cognitive Disorders Depression Geriatrics Health Sciences Inflammation Macular Degeneration Medication Ophthalmology Parkinson's Disease Surgery Abnormal Psychology

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 7.67
    IBRN D iShares Neuroscience and Healthcare ETF 4.94
    ARKG F ARK Genomic Revolution Multi-Sector ETF 4.43
    MNTL D Tema Neuroscience and Mental Health ETF 4.27
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 3.97
    View all Disorders ETFs...
    Compare ETFs
    Compare ARKG to MNTL Compare PBE to ARKG Compare PBE to SURI

        Disorders Stocks Recent News

        Date Stock Title
        May 13 REGN Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
        May 13 REGN Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
        May 13 REGN Pipeline Moves: Phase III completion for Corcept’s relaorilant
        May 13 REGN Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
        May 10 OMER Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
        May 10 REGN Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week
        May 10 REGN Q1 2024 Intellia Therapeutics Inc Earnings Call
        May 9 CPRX HHS panel to vote in Nov. on DMD screening for newborns
        May 9 CPRX Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript
        May 9 OMER Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
        May 9 ELDN Eledon Pharmaceuticals GAAP EPS of -$0.34 beats by $0.04
        May 9 ELDN Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
        May 9 ELDN Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
        May 9 REGN Regeneron’s gene therapy triumphs twice, restoring hearing in children
        May 8 CPRX Catalyst Pharmaceuticals Non-GAAP EPS of $0.38 beats by $0.08, revenue of $98.44M misses by $0.33M
        May 8 CPRX Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
        May 8 REGN Regeneron gene therapy improves hearing in child deafness
        May 8 REGN Regeneron gene therapy improves hearing in two children
        May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
        May 7 CPRX Catalyst Pharmaceuticals Q1 2024 Earnings Preview
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Medicine Biopharmaceutical Alcohol Anemia Angioedema Biotechnology Diabetes Disease Dystrophy Epilepsy Hematology Hematopathology Hereditary Angioedema Hypertension Kidney Failure Organ Systems Pain Rare Diseases Acromegaly Alpha 1 Antitrypsin
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags